Published in Gastroenterology on May 01, 1992
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut (2005) 3.31
Influence of treatment on morphological features of mucosal inflammation. Gut (2002) 1.37
Recent advances of endoscopy in inflammatory bowel diseases. Gut Liver (2007) 1.17
Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis. World J Gastroenterol (2012) 1.16
Role of endoscopy in predicting the disease course in inflammatory bowel disease. World J Gastroenterol (2010) 0.93
Enteral nutrition in Crohn's disease: an underused therapy. Gastroenterol Res Pract (2013) 0.88
Ileoscopy via stoma after diverting ileostomy: a safe and effective tool to evaluate for Crohn's recurrence of neoterminal ileum. Dig Dis Sci (2010) 0.86
Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. The Budesonide Study Group. Gut (1998) 0.86
Labelled leucocyte scintigraphy in inflammatory bowel disease: clinical applications. Gut (1996) 0.84
The role of mucosal healing in the treatment of patients with inflammatory bowel disease. Curr Treat Options Gastroenterol (2014) 0.81
Targeting mucosal healing in Crohn's disease. Gastroenterol Hepatol (N Y) (2011) 0.78
Taking Crohn's disease personally. Rambam Maimonides Med J (2013) 0.76
Does endoscopic assessment of mucosal healing affect IBD management? Dig Dis Sci (2014) 0.75
Usefulness of Endoscopic Indices in Determination of Disease Activity in Patients with Crohn's Disease. Gastroenterol Res Pract (2016) 0.75
Analysis of biological variables in Crohn's disease. Gut (1996) 0.75
Mucosal healing effect of nilotinib in indomethacin-induced enterocolitis: A rat model. World J Gastroenterol (2015) 0.75
Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers. BMC Med Imaging (2016) 0.75
Standards of medical treatment and nutrition in Crohn's disease. Langenbecks Arch Surg (2004) 0.75
Endoluminal ultrasound biomicroscopy as a reliable tool for in vivo assessment of colonic inflammation in rats. Int J Colorectal Dis (2013) 0.75
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature (1996) 5.44
Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology (1998) 5.02
Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology (1990) 4.78
European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59
Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria. J Hepatol (1993) 3.24
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology (2000) 2.78
Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology (1996) 2.61
Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives. Gastroenterology (1990) 2.58
A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group. N Engl J Med (1998) 2.54
Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology (1995) 2.47
Diagnostic value of endoscopic capsule in patients with obscure digestive bleeding: blinded comparison with video push-enteroscopy. Endoscopy (2003) 2.20
Treatment of Crohn's disease by lymphocyte apheresis: a randomized controlled trial. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gastroenterology (1994) 2.07
Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol (1998) 2.03
Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study). J Clin Invest (1985) 2.00
The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. Br J Clin Pharmacol (1989) 1.92
Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol (1996) 1.89
Are complicated forms of celiac disease cryptic T-cell lymphomas? Blood (1998) 1.87
Incidence of inflammatory bowel disease in northern France (1988-1990). Gut (1994) 1.81
Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology (2001) 1.73
Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis. Gastroenterology (1996) 1.73
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID) Gastroenterology (1993) 1.71
Clinical characteristics of Crohn's disease in 72 families. Gastroenterology (1996) 1.70
The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007). Aliment Pharmacol Ther (2011) 1.69
Methotrexate in Crohn's disease: long-term efficacy and toxicity. Am J Gastroenterol (2000) 1.69
Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology (1997) 1.69
Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology (1999) 1.68
Treatment of diversion colitis by short-chain fatty acids. Prospective and double-blind study. Dis Colon Rectum (1991) 1.65
Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut (2005) 1.65
Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies. Gut (1986) 1.63
Control of acute Zollinger-Ellison syndrome with intravenous omeprazole. Lancet (1982) 1.63
Genetically related Escherichia coli strains associated with Crohn's disease. Gut (2001) 1.61
Effect of indinavir on HIV-related wasting. AIDS (1998) 1.59
Inflammatory bowel disease in married couples: 10 cases in Nord Pas de Calais region of France and Liège county of Belgium. Gut (1994) 1.57
Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study. Gut (1999) 1.56
The clinicopathological features of extensive small intestinal CD4 T cell infiltration. Gut (1999) 1.54
Perioperative endoscopy of the whole small bowel in Crohn's disease. Gut (1993) 1.54
Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients. Hepatology (1989) 1.50
Investigation of drug absorption from the gastrointestinal tract of man. I. Metoprolol in the stomach, duodenum and jejunum. Br J Clin Pharmacol (1985) 1.48
Macronutrient intake and malabsorption in HIV infection: a comparison with other malabsorptive states. Gut (1997) 1.46
Factors of weight loss in patients with HIV and chronic diarrhea. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.45
Decision-making in dyspepsia: controversies in primary and secondary care. Eur J Gastroenterol Hepatol (1999) 1.43
Evidence of gastritis with several Helicobacter pylori strains. Lancet (1989) 1.43
Use of scanning electron microscopy to investigate dental calculus in dogs. Vet Rec (1990) 1.43
Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison. Br J Cancer (2005) 1.42
Diagnosis of protein-losing enteropathy by gastrointestinal clearance of alpha1-antitrypsin. Lancet (1978) 1.41
[Infliximab therapy for Crohn's disease anoperineal lesions]. Gastroenterol Clin Biol (2001) 1.40
[Acute reversible pan-dysautonomia: effect of erythromycin on gastrointestinal involvement]. Gastroenterol Clin Biol (1997) 1.40
Crohn's disease clinical course and severity in obese patients. Clin Nutr (2002) 1.40
Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression. Aliment Pharmacol Ther (2008) 1.40
[Adult asthma exacerbations in questions]. Rev Mal Respir (2010) 1.40
[Diagnostic and therapeutic management of patients with chronic inflammatory bowel disease]. Rev Epidemiol Sante Publique (1999) 1.39
[Antro-pyloro-bulbar contractibility in diabetics studied by cineradiography. Effect of erythromycin]. Gastroenterol Clin Biol (1993) 1.39
[A cause of terminal constipation: hypertonia of the striated pelvic muscle. Value of complementary studies]. Gastroenterol Clin Biol (1988) 1.39
Intestinal clearance of alpha 1-antitrypsin. A sensitive method for the detection of protein-losing enteropathy. Gastroenterology (1981) 1.39
Three-dimensional conformal radiotherapy in the treatment of prostate cancer in Australia and New Zealand: Report on a survey of radiotherapy centres and the proceedings of a consensus workshop. Australas Radiol (2004) 1.38
Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig Dis Sci (1997) 1.33
[Cerebrovascular accidents after endoscopic obturation of esophageal varices with isobutyl-2-cyanoacrylate in 2 patients]. Gastroenterol Clin Biol (1987) 1.33
Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut (1997) 1.31
Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein. Clin Exp Immunol (1988) 1.29
Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet. Gut (1991) 1.28
Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol (2001) 1.27
Palliative treatment of rectosigmoid carcinoma by laser endoscopic photoablation. Gastroenterology (1987) 1.27
The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr (1997) 1.26
Antibiotics in Crohn's disease. Gut (2001) 1.25
Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol (2001) 1.24
Clinical impact of capsule endoscopy compared to push enteroscopy: 1-year follow-up study. Endoscopy (2005) 1.22
Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999). Gut (2004) 1.20
A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis. Gut (2003) 1.19
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies. Aliment Pharmacol Ther (2010) 1.18
Colonic metabolism of wheat starch in healthy humans. Effects on fecal outputs and clinical symptoms. Gastroenterology (1986) 1.18
Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology (1999) 1.17
Is there more than one late radiation proctitis syndrome? Radiother Oncol (1999) 1.14
Drug induced lymphocytic colitis. Gut (1994) 1.13
Impaired bacterial flora in human excluded colon. Gut (1989) 1.12
Cap polyposis occurring in the postoperative course of pelvic surgery. Gut (1994) 1.12
Qualitative study of fecal alpha 1-proteinase inhibitor in normal subjects and patients with Crohn's disease. Clin Chem (1988) 1.11
Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients. Gut (1992) 1.10
Idiopathic pancreatitis associated with inflammatory bowel disease. Dig Dis Sci (1985) 1.10
Current approach to the management of tumoral process in patients with gastrinoma. World J Surg (1986) 1.09
Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut (1995) 1.09
Villous adenomas of the rectum. Results of endoscopic treatment with argon and Nd:YAG lasers. Gastroenterology (1985) 1.09
Oral Crohn disease: clinical characteristics and long-term follow-up of 9 cases. Arch Dermatol (1999) 1.06
Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial. Gut (1988) 1.06
Inflammatory bowel disease in spouses and their offspring. Gastroenterology (2001) 1.05
Anticipation in familial Crohn's disease. Gut (1998) 1.04
Bacterial translocation in colorectal cancers. Gastroenterol Clin Biol (1990) 1.04
[Inflammatory polyarthritis associated with villous atrophy of the small intestine. Study of 2 cases]. Rev Rhum Mal Osteoartic (1980) 1.04